Alx Oncology Holdings (ALXO) Tax Provisions (2019 - 2020)
Alx Oncology Holdings (ALXO) reported Tax Provisions of $182000.0 for Q4 2020, up 1922.22% on a YoY basis from $9000.0 in Q1 2020, and up 420.0% sequentially from $35000.0 in Q3 2020.
Alx Oncology Holdings (ALXO) Tax Provisions (2019 - 2020) Analysis & Trends
Alx Oncology Holdings (ALXO) has 2 years of Tax Provisions data on file, last reported at $182000.0 in Q4 2020.
- For the quarter ending Q4 2020, Tax Provisions rose 1922.22% year-over-year to $182000.0; the trailing twelve-month figure through Dec 2020 stood at $241000.0 (changed N/A YoY), and the FY2024 full-year result was -$28.3 million, changed N/A from the prior year.
- Tax Provisions advanced to $182000.0 in Q4 2020, from $35000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $182000.0 in Q4 2020 to a low of $4000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alx Oncology Holdings | 211.24 Mn | 211.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 182,000.00 |
| Sep 30, 2020 | 35,000.00 |
| Jun 30, 2020 | 20,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 8,000.00 |
| Jun 30, 2019 | 8,000.00 |